Institute for Clinical Systems Improvement: Venous thromboembolism (VTE) diagnosis and treatment

Institute for Clinical Systems Improvement

Venous thromboembolism (VTE) diagnosis and treatment: percentage of adult patients suspected of deep vein thrombosis (DVT) who have leg duplex ultrasound with compression performed despite a low clinical pretest probability and a negative D-dimer test. This updates a previously published measure summary.
abrir aquí:
http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?ss=1&doc_id=14566

Venous thromboembolism (VTE) diagnosis and treatment: percentage of adult patients treated for VTE who have been assessed for the need for graded compression stockings (not Teds). This updates a previously published measure summary.
abrir aquí:
http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?ss=1&doc_id=14563


Venous thromboembolism (VTE) diagnosis and treatment: percentage of adult patients who have a high clinical pretest probability for pulmonary embolism (PE) who received low molecular weight heparin (LMWH) during evaluation. This updates a previously published measure summary.
abrir aquí:
http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?ss=1&doc_id=14564


Venous thromboembolism (VTE) diagnosis and treatment: percentage of low-molecular-weight heparin (LMWH)-eligible patients with deep vein thrombosis (DVT) treated in an outpatient setting. This updates a previously published measure summary.
abrir aquí:
http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?ss=1&doc_id=14568

Venous thromboembolism (VTE) diagnosis and treatment: percentage of patients diagnosed with VTE who meet the criteria for low-molecular-weight heparin (LMWH) and for whom LMWH is used. This updates a previously published measure summary.
abrir aquí:
http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?ss=1&doc_id=14567


Venous thromboembolism (VTE) diagnosis and treatment: percentage of patients with VTE receiving heparin therapy who have a baseline platelet count before starting heparin, and then a platelet count every other day for at least the first 3 days of therapy. This updates a previously published measure summary.
abrir aquí:
http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?ss=1&doc_id=14565